For most people with vitiligo, the treatment journey begins with topical creams and phototherapy. But for some — especially those with stable vitiligo that has resisted conventional treatment — surgery offers a powerful alternative. Advances in melanocyte transplantation techniques have made surgical repigmentation more precise, more successful, and more accessible than ever before.
What Is Melanocyte Transplantation?
Melanocytes are the specialized skin cells responsible for producing melanin, the pigment that gives skin its color. In vitiligo, these cells are attacked and destroyed by the immune system. Melanocyte transplantation involves harvesting healthy melanocytes from an unaffected area of the patient's own skin (called a donor site) and transplanting them into the depigmented patches.
Because the cells come from the patient's own body, there is no risk of rejection.
The Main Surgical Approaches
1. Non-Cultured Epidermal Cell Suspension (NCECS)
This is currently the most widely used and most praised surgical technique. A small patch of normal skin is harvested (usually from the thigh or buttock), the melanocytes and keratinocytes are extracted using a simple enzymatic process, and the resulting cell suspension is applied to the prepared (dermabrazed or laser-treated) vitiligo patches.
A 2025 chapter in a major dermatology textbook described NCECS as having "revolutionized the surgical management of vitiligo" — results in terms of color matching and repigmentation percentage are significantly better than earlier grafting techniques, with a relatively simple procedure that can be completed in a clinic setting.
2. Split-Thickness Skin Grafting (STSG)
In this traditional approach, a thin layer of skin is taken from a donor site and grafted directly onto the vitiligo patches. It is effective but leaves a scar at the donor site and requires more precise technique for color matching. It tends to work better for smaller, stable patches.
3. Hair Follicle-Derived Melanocyte Transplantation
A newer approach explores harvesting melanocytes from hair follicles — the stem cell reservoir from which melanocytes naturally re-emerge after phototherapy. A 2026 study in PMC showed promising results, particularly for patients with limited donor skin availability. This technique may become increasingly important as the field matures.
Who Is a Candidate?
Not everyone with vitiligo is a surgical candidate. The key criteria are:
Stable vitiligo: No new patches or spreading for at least 1–2 years (depending on the surgical protocol)
No active Koebner phenomenon: The tendency for vitiligo to spread to traumatized skin must not be active, as surgery involves skin trauma
Motivation and realistic expectations: Surgery provides repigmentation, but color may not match perfectly, and maintenance treatment (NB-UVB) is usually needed afterward to stimulate and integrate the transplanted cells
Areas with the best surgical outcomes include the face, neck, and trunk. Acral sites (hands, feet) and areas over joints historically show lower success rates, though newer techniques continue to improve results in these challenging locations.
Recovery and Results
Recovery from NCECS is generally straightforward. The donor site heals within 1–2 weeks with proper dressing. The treated vitiligo areas are typically bandaged for a week before reassessment. Initial repigmentation begins to appear within 4–6 weeks as melanocytes establish themselves, with full color development taking 3–6 months. Subsequent phototherapy sessions help stimulate even color spread.
Success rates vary by technique and body site, but well-selected patients achieving >75% repigmentation of treated areas are commonly reported in published case series.
No comments:
Post a Comment